Suvretta Capital Management
Latest statistics and disclosures from Suvretta Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ARQT, Veradermics, SPY, PVLA, APLS, and represent 27.24% of Suvretta Capital Management's stock portfolio.
- Added to shares of these 10 stocks: Veradermics (+$263M), CAPR (+$62M), VMC (+$49M), CRNX (+$38M), USFD (+$37M), MGM (+$35M), PFGC (+$33M), PVLA (+$33M), REPL (+$32M), COF (+$24M).
- Started 15 new stock positions in VST, VMC, SPOT, TLN, GWW, WING, SNSE, CRNX, Satellos Bioscience, PFGC. LTH, RBLX, AVR, Veradermics, USFD.
- Reduced shares in these 10 stocks: SPY (-$293M), ARKG (-$242M), ERAS (-$179M), KO (-$97M), HIMS (-$83M), , MSFT (-$57M), , RARE (-$46M), .
- Sold out of its positions in ARKG, BIIB, CRL, CMG, KO, DKS, EXACT Sciences Corporation, GS, HIMS, INSM. MRNA, ORCL, RCKT, CRM, NOW, TNGX, RARE, UTHR, QURE.
- Suvretta Capital Management was a net seller of stock by $-840M.
- Suvretta Capital Management has $3.9B in assets under management (AUM), dropping by -19.80%.
- Central Index Key (CIK): 0001569064
Tip: Access up to 7 years of quarterly data
Positions held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Suvretta Capital Management
Suvretta Capital Management holds 89 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics (ARQT) | 7.4 | $290M | +3% | 12M | 23.56 |
|
| Veradermics Common Stock | 6.7 | $263M | NEW | 4.2M | 63.15 |
|
| State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY) | 5.8 | $228M | -56% | 350k | 650.34 |
|
| Palvella Therapeutics Inc Ne (PVLA) | 3.7 | $144M | +29% | 1.2M | 124.65 |
|
| Apellis Pharmaceuticals (APLS) | 3.6 | $142M | -15% | 3.5M | 40.23 |
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 3.5 | $137M | +14% | 7.6M | 18.09 |
|
| Benitec Biopharma Com New (BNTC) | 3.1 | $123M | 12M | 10.65 |
|
|
| Capricor Therapeutics Com New (CAPR) | 3.0 | $116M | +113% | 3.8M | 30.40 |
|
| Immatics SHS (IMTX) | 2.8 | $110M | 11M | 9.84 |
|
|
| Arcus Biosciences Incorporated (RCUS) | 2.8 | $109M | -3% | 5.0M | 21.60 |
|
| Eyepoint Com New (EYPT) | 2.7 | $107M | +5% | 8.3M | 12.89 |
|
| Arrivent Biopharma (AVBP) | 2.6 | $102M | +7% | 4.4M | 23.07 |
|
| Taiwan Semiconductor Manufac Sponsored Ads (TSM) | 2.6 | $101M | +10% | 299k | 337.95 |
|
| NVIDIA Corporation (NVDA) | 2.6 | $100M | +8% | 575k | 174.40 |
|
| Meta Platforms Cl A (META) | 2.5 | $97M | 170k | 572.13 |
|
|
| Kalvista Pharmaceuticals (KALV) | 2.5 | $96M | 4.8M | 20.13 |
|
|
| Ge Aerospace Com New (GE) | 2.2 | $88M | 310k | 283.77 |
|
|
| Biohaven (BHVN) | 2.2 | $87M | 10M | 8.46 |
|
|
| SYSCO Corporation (SYY) | 2.1 | $83M | +6% | 1.2M | 71.33 |
|
| MGM Resorts International. (MGM) | 2.0 | $80M | +79% | 2.2M | 37.01 |
|
| Compass Therapeutics (CMPX) | 1.9 | $76M | 14M | 5.29 |
|
|
| Home Depot (HD) | 1.9 | $73M | -8% | 222k | 328.89 |
|
| Kura Oncology (KURA) | 1.8 | $70M | 8.6M | 8.13 |
|
|
| Monte Rosa Therapeutics (GLUE) | 1.8 | $70M | +25% | 4.2M | 16.45 |
|
| Bank of America Corporation (BAC) | 1.6 | $63M | -14% | 1.3M | 48.75 |
|
| Erasca (ERAS) | 1.4 | $56M | -76% | 3.4M | 16.18 |
|
| Capital One Financial (COF) | 1.4 | $55M | +75% | 302k | 182.43 |
|
| Zura Bio Class A Ord Shs (ZURA) | 1.4 | $54M | +62% | 9.1M | 5.95 |
|
| Amazon (AMZN) | 1.4 | $53M | -37% | 254k | 208.27 |
|
| Advanced Micro Devices (AMD) | 1.3 | $52M | -33% | 257k | 203.43 |
|
| Fulcrum Therapeutics (FULC) | 1.3 | $50M | 6.6M | 7.67 |
|
|
| Vulcan Materials Company (VMC) | 1.3 | $49M | NEW | 182k | 272.30 |
|
| Ferguson Enterprises Common Stock New (FERG) | 1.3 | $49M | +33% | 212k | 233.26 |
|
| Apollo Global Mgmt (APO) | 1.1 | $43M | -28% | 388k | 111.42 |
|
| Mineralys Therapeutics (MLYS) | 1.1 | $42M | 1.5M | 27.09 |
|
|
| Crinetics Pharmaceuticals In (CRNX) | 1.0 | $38M | NEW | 1.0M | 36.32 |
|
| Contineum Therapeutics Cl A (CTNM) | 0.9 | $37M | 2.8M | 13.06 |
|
|
| Us Foods Hldg Corp call (USFD) | 0.9 | $37M | NEW | 396k | 92.21 |
|
| Performance Food (PFGC) | 0.8 | $33M | NEW | 387k | 85.66 |
|
| Replimune Group (REPL) | 0.8 | $32M | +11614% | 4.2M | 7.65 |
|
| Advisorshares Tr Pure Us Cannabis (MSOS) | 0.8 | $32M | +4% | 9.0M | 3.55 |
|
| Aura Biosciences (AURA) | 0.7 | $29M | 4.4M | 6.69 |
|
|
| UnitedHealth (UNH) | 0.7 | $27M | -9% | 101k | 270.59 |
|
| Prokidney Corp Shs Cl A (PROK) | 0.6 | $22M | 12M | 1.79 |
|
|
| Life Time Group Holdings Common Stock (LTH) | 0.4 | $14M | NEW | 510k | 26.94 |
|
| Aadi Bioscience (WHWK) | 0.3 | $13M | 3.7M | 3.45 |
|
|
| Abeona Therapeutics Com New (ABEO) | 0.3 | $12M | 2.7M | 4.48 |
|
|
| Wingstop (WING) | 0.2 | $9.2M | NEW | 60k | 154.97 |
|
| Molecular Partners Ads (MOLN) | 0.2 | $8.8M | 2.2M | 3.97 |
|
|
| Boston Scientific Corporation (BSX) | 0.2 | $7.8M | -64% | 124k | 62.75 |
|
| Lexeo Therapeutics (LXEO) | 0.2 | $7.2M | 1.3M | 5.74 |
|
|
| Coherent Corp (COHR) | 0.2 | $7.1M | -78% | 30k | 238.21 |
|
| Inflarx Nv (IFRX) | 0.2 | $7.1M | 7.9M | 0.89 |
|
|
| Danaher Corporation (DHR) | 0.2 | $6.9M | -85% | 36k | 189.60 |
|
| Abbott Laboratories (ABT) | 0.2 | $6.9M | +31% | 67k | 102.67 |
|
| Thermo Fisher Scientific (TMO) | 0.2 | $6.6M | 13k | 491.53 |
|
|
| Medtronic SHS (MDT) | 0.2 | $6.3M | +188% | 72k | 86.65 |
|
| Johnson & Johnson (JNJ) | 0.1 | $5.7M | -76% | 23k | 244.44 |
|
| Kezar Life Sciences Com New (KZR) | 0.1 | $5.3M | 717k | 7.42 |
|
|
| Intuitive Surgical Com New (ISRG) | 0.1 | $5.2M | +117% | 11k | 460.99 |
|
| Anteris Technologies Global (AVR) | 0.1 | $4.7M | NEW | 850k | 5.55 |
|
| AmerisourceBergen (COR) | 0.1 | $3.9M | 13k | 314.14 |
|
|
| Satellos Bioscience | 0.1 | $2.7M | NEW | 475k | 5.63 |
|
| Mettler-Toledo International (MTD) | 0.1 | $2.5M | 2.0k | 1261.20 |
|
|
| Natera (NTRA) | 0.1 | $2.0M | 10k | 199.99 |
|
|
| Dex (DXCM) | 0.1 | $2.0M | 32k | 62.80 |
|
|
| Stryker Corporation (SYK) | 0.0 | $1.9M | 5.9k | 328.59 |
|
|
| Tesla Motors (TSLA) | 0.0 | $1.9M | -94% | 5.2k | 371.75 |
|
| Talen Energy Corp (TLN) | 0.0 | $1.9M | NEW | 6.0k | 319.23 |
|
| Medline Com Cl A (MDLN) | 0.0 | $1.9M | 43k | 44.50 |
|
|
| Microsoft Corporation (MSFT) | 0.0 | $1.8M | -96% | 5.0k | 370.17 |
|
| McKesson Corporation (MCK) | 0.0 | $1.6M | 1.8k | 865.36 |
|
|
| Hca Holdings (HCA) | 0.0 | $1.5M | 3.2k | 473.24 |
|
|
| Edwards Lifesciences (EW) | 0.0 | $1.5M | +68% | 19k | 80.08 |
|
| Iqvia Holdings (IQV) | 0.0 | $1.2M | 7.2k | 170.54 |
|
|
| W.W. Grainger (GWW) | 0.0 | $1.1M | NEW | 1.0k | 1090.81 |
|
| Sensei Biotherapeutics Com New (SNSE) | 0.0 | $1.1M | NEW | 35k | 31.52 |
|
| Waters Corporation (WAT) | 0.0 | $960k | +2% | 3.2k | 297.80 |
|
| Vistra Energy (VST) | 0.0 | $902k | NEW | 6.0k | 150.33 |
|
| Ionis Pharmaceuticals (IONS) | 0.0 | $811k | 11k | 75.09 |
|
|
| Agilent Technologies Inc C ommon (A) | 0.0 | $569k | 5.0k | 113.98 |
|
|
| ResMed (RMD) | 0.0 | $537k | 2.4k | 224.48 |
|
|
| Spotify Technology S A SHS (SPOT) | 0.0 | $533k | NEW | 1.1k | 484.91 |
|
| Veralto Corp Com Shs (VLTO) | 0.0 | $484k | 5.5k | 88.42 |
|
|
| Roblox Corp Cl A (RBLX) | 0.0 | $476k | NEW | 8.4k | 56.56 |
|
| Sarepta Therapeutics (SRPT) | 0.0 | $389k | 18k | 21.76 |
|
|
| Steris Shs Usd (STE) | 0.0 | $338k | 1.5k | 221.13 |
|
|
| Miragen Therapeutics (VRDN) | 0.0 | $327k | 17k | 19.56 |
|
|
| Zimmer Holdings (ZBH) | 0.0 | $295k | 3.3k | 90.42 |
|
Past Filings by Suvretta Capital Management
SEC 13F filings are viewable for Suvretta Capital Management going back to 2013
- Suvretta Capital Management 2026 Q1 filed May 15, 2026
- Suvretta Capital Management 2025 Q4 filed Feb. 17, 2026
- Suvretta Capital Management 2025 Q3 filed Nov. 14, 2025
- Suvretta Capital Management 2025 Q2 filed Aug. 14, 2025
- Suvretta Capital Management 2025 Q1 filed May 15, 2025
- Suvretta Capital Management 2024 Q4 filed Feb. 14, 2025
- Suvretta Capital Management 2024 Q3 filed Nov. 14, 2024
- Suvretta Capital Management 2024 Q2 filed Aug. 14, 2024
- Suvretta Capital Management 2024 Q1 filed May 15, 2024
- Suvretta Capital Management 2023 Q3 filed Nov. 14, 2023
- Suvretta Capital Management 2023 Q2 filed Aug. 14, 2023
- Suvretta Capital Management 2023 Q1 filed May 15, 2023
- Suvretta Capital Management 2022 Q4 filed Feb. 14, 2023
- Suvretta Capital Management 2022 Q3 filed Nov. 14, 2022
- Suvretta Capital Management 2022 Q2 filed Aug. 15, 2022
- Suvretta Capital Management 2022 Q1 filed May 16, 2022